CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer
Go back to CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer| Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) | Delayed: 3.57 +0.18 (5.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.39 | 52 Week High | $24.68 | |||
| Open | $3.48 | 52 Week Low | $9.10 | |||
| Day High | $3.60 | P/E | N/A | |||
| Day Low | $3.46 | EPS | $0.00 | |||
| Volume | 2,770,817 | |||||
